Sabapathy, S. et al. 2018. COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA. Journal of Population Therapeutics and Clinical Pharmacology. 23, 2 (Nov. 2018).